Indeed, Kinkade et al. have demonstrated that combinatorial blockade of MEK and mTOR signaling was highly synergistic, as compared to single-pathway inhibition, in terms of growth and proliferation inhibition of castration-resistant prostate cancer in the Nkx3.1, PTEN-mutant, mouse model23. The gene discussed is PTEN; the disease is prostate carcinoma.